Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Assess historical performance and potential in retirement for SP500 and Total Market funds, focusing on consistency and drawdown behavior.
28,444 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Dow's Jim Fitterling cautions that the Iran war is disrupting petrochemical supply, potentially fueling inflation thr...
Ford CEO Jim Farley reveals his son will spend the summer fabricating rather than attending traditional classes, spot...
Solana surged 13% last week, its strongest performance of 2026, driven by ETF demand and higher futures activity. Tra...
Sponsors are pulling back after reports of a strip club atmosphere at a major crypto conference after-party in Miami....
PepsiCo’s chief people officer says the company wins by hiring people who hustle, stay curious, and adapt quickly in ...
A Deloitte-recognized fast-growing software company launches a phone-scrolling earnings program, sending shares aroun...
A note from Standard Chartered suggests bitcoin's bottom could be in sight after a tough week, driven by steady ETF d...
Realtracs says the Zillow listing feed will continue past the June 8 deadline while it negotiates new licensing terms...
Bitcoin is within roughly 9,500 blocks of a pivotal activation window that could redraw its governance playbook. The ...
AI demand has sparked a rapid rally in memory stocks, but signs of inventory normalization and pricing pressure pose ...
Rising fuel costs push households to seek steadier income. This report explains how a portfolio that quietly pays can...